Bill Summary: SB00328

• Establishes an Office of Health Strategy within the Department of Public Health to develop health care cost growth benchmarks and quality benchmarks, with the goal of reaching 10% primary care spending by 2025.

• Creates a Canadian drug reimportation program allowing the Commissioner of Consumer Protection to import safe legend drugs from Canada, subject to federal approval under 21 USC 384, with participating wholesalers and suppliers required to conduct laboratory testing and maintain track-and-trace records.

• Implements new restrictions on medical stop-loss insurance policies effective January 1, 2021, including minimum annual attachment points of $20,000 per employee and prohibits insurers from denying coverage based on pre-existing conditions (lasering), with limited exceptions requiring full disclosure.

• Authorizes the Office of Health Strategy to seek a Section 1332 state innovation waiver from the federal government to establish a reinsurance program for the individual health insurance market, funded up to $21.21 million annually to lower premiums.

• Requires health care entities and payers exceeding cost growth benchmarks to submit performance improvement plans and participate in public hearings, with the office maintaining confidentiality of submitted clinical and financial information.